Citation Impact
Citing Papers
Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management Care
2016
DNA Methylation in Serum and Tumors of Cervical Cancer Patients
2004
Nucleic acid detection with CRISPR-Cas13a/C2c2
2017 StandoutScience
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
2016
Cell-Free Nucleic Acids Circulating in the Plasma of Colorectal Cancer Patients Induce the Oncogenic Transformation of Susceptible Cultured Cells
2010
Positional cloning of the wheat vernalization gene VRN1
2003 Standout
Circulating microRNAs as stable blood-based markers for cancer detection
2008 Standout
High burden and pervasive positive selection of somatic mutations in normal human skin
2015 StandoutScience
Ultrasensitive Measurement of Hotspot Mutations in Tumor DNA in Blood Using Error-Suppressed Multiplexed Deep Sequencing
2012
fastp: an ultra-fast all-in-one FASTQ preprocessor
2018 Standout
Infrared molecular fingerprinting of blood-based liquid biopsies for the detection of cancer
2021 StandoutNobel
Quantification of Free Circulating Tumor DNA as a Diagnostic Marker for Breast Cancer
2008
Features of systemic lupus erythematosus in mice injected with bacterial lipopolysaccharides: identificantion of circulating DNA and renal localization of DNA-anti-DNA complexes.
1977
Noninvasive in vivo monitoring of tissue-specific global gene expression in humans
2014
Use of Liquid Biopsies in Clinical Oncology: Pilot Experience in 168 Patients
2016
A Minimally-invasive Blood-derived Biomarker of Oligodendrocyte Cell-loss in Multiple Sclerosis
2016
Cell-free circulating tumor DNA in cancer
2016
Prognostic value of genomic alterations in minimal residual cancer cells purified from the blood of breast cancer patients
2000
The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients
2009
Breast-cancer detection using blood-based infrared molecular fingerprints
2021 StandoutNobel
Frequent copresence of methylated DNA and fragmented nucleosomal DNA in plasma of lymphoma patients
2003
Higher Amount of Free Circulating DNA in Serum than in Plasma Is Not Mainly Caused by Contaminated Extraneous DNA during Separation
2006
Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease
2010
The role of macrophages in the in vitro generation of extracellular DNA from apoptotic and necrotic cells
2005
The value of serial plasma nuclear and mitochondrial DNA levels in patients with acute ischemic stroke
2010
A view on drug resistance in cancer
2019 StandoutNature
Comparative Analysis of Mesenteric and Peripheral Blood Circulating Tumor DNA in Colorectal Cancer Patients
2006
Salivary Transcriptomic Biomarkers for Detection of Resectable Pancreatic Cancer
2009
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Epigenetics in human disease and prospects for epigenetic therapy
2004 StandoutNature
Circulating cell free DNA: Preanalytical considerations
2013
The biology and management of non-small cell lung cancer
2018 StandoutNature
Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load
2013
Detection of Microsatellite Alterations in the DNA Isolated from Tumor Cells and from Plasma DNA of Patients with Lung Cancer
2000
About the possible origin and mechanism of circulating DNA
2001
Detection of p16 hypermethylation in circulating plasma DNA of non-small cell lung cancer patients
2002
Microsatellite analysis of serum DNA in patients with head and neck cancer
2004
Lung Cancer
2008 Standout
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Cancer epidemiology in the last century and the next decade
2001 Nature
Fragment Length of Circulating Tumor DNA
2016
The power and the promise of DNA methylation markers
2003
Circulating cell-free and Epstein–Barr virus DNA in pediatric B-non-Hodgkin lymphomas
2010
CpG motifs in bacterial DNA trigger direct B-cell activation
1995 StandoutNature
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
2010 StandoutNature
Carrier molecules and extraction of circulating tumor DNA for next generation sequencing in colorectal cancer
2016
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNA
2012
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators
2007
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
The Emerging Role of “Liquid Biopsies,” Circulating Tumor Cells, and Circulating Cell-Free Tumor DNA in Lung Cancer Diagnosis and Identification of Resistance Mutations
2017
Plasma Epstein-Barr Virus DNA and Residual Disease After Radiotherapy for Undifferentiated Nasopharyngeal Carcinoma
2002
Human papillomavirus DNA in plasma of patients with cervical cancer
2001
Epigenetics in Cancer
2008 Standout
Cell-free and cell-bound circulating DNA in breast tumours: DNA quantification and analysis of tumour-related gene methylation
2006
Metagenomic biomarker discovery and explanation
2011 Standout
Serum LINE-1 hypomethylation as a potential prognostic marker for hepatocellular carcinoma
2007
Hypermethylation of p16INK4a in Chinese lung cancer patients: biological and clinical implications
2003
DNA‐Based Detection of Prostate Cancer in Blood, Urine, and Ejaculates
2001
Global cancer statistics
2011 Standout
Human Urine Contains Small, 150 to 250 Nucleotide-Sized, Soluble DNA Derived from the Circulation and May Be Useful in the Detection of Colorectal Cancer
2004
The Long and Short of Circulating Cell-Free DNA and the Ins and Outs of Molecular Diagnostics
2016
Ser‐249TP53 mutation in tumour and plasma DNA of hepatocellular carcinoma patients from a high incidence area in the Gambia, West Africa
2004
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Multi‐marker analysis of circulating cell‐free DNA toward personalized medicine for colorectal cancer
2014
Gene methylation and early detection of genitourinary cancer: the road ahead
2007
Circulating Nucleic Acids in Plasma and Serum
2008
Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening
2009
Emerging molecular markers of cancer
2002
Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA
2015
Tumor-specific DNA in plasma of breast cancer patients
2002
Detection of p53 mutations in the plasma DNA of patients with ovarian cancer
2004
Circulating free DNA in plasma or serum as biomarker of carcinogenesis: Practical aspects and biological significance
2007
Strategies for early detection of resectable pancreatic cancer
2014
Floral dip: a simplified method forAgrobacterium‐mediated transformation ofArabidopsis thaliana
1998 Standout
Presence of fetal DNA in maternal plasma and serum
1997 Standout
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Tumor-specific p53 sequences in blood and peritoneal fluid of women with epithelial ovarian cancer
2005
Gene Silencing in Cancer in Association with Promoter Hypermethylation
2003 Standout
Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer
2006
Detection of free‐circulating tumor‐associated DNA in plasma of colorectal cancer patients and its association with prognosis
2002
Detection of tumor‐specific DNA in blood and bone marrow plasma from patients with prostate cancer
2007
Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets
2015 Standout
Rapid Clearance of Fetal DNA from Maternal Plasma
1999
Direct Quantification of Cell-Free, Circulating DNA from Unpurified Plasma
2014
Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing
2008
Quantitative Analysis of Fetal DNA in Maternal Plasma and Serum: Implications for Noninvasive Prenatal Diagnosis
1998 Standout
New evidence that a large proportion of human blood plasma cell-free DNA is localized in exosomes
2017
Circulating Nucleic Acids in Plasma and Serum
2006
Maternal Plasma Cell-Free Fetal and Maternal DNA at 11-13 Weeks' Gestation: Relation to Fetal and Maternal Characteristics and Pregnancy Outcomes
2013
Nucleosomes in serum of patients with benign and malignant diseases
2001
Circulating DNA Microsatellites: Molecular Determinants of Response to Biochemotherapy in Patients With Metastatic Melanoma
2004
Genomic analysis of circulating cell-free DNA infers breast cancer dormancy
2011
TP53 mutations in circulating free DNA from Egyptian patients with non-Hodgkin’s lymphoma
2008
Actual Causes of Death in the United States, 2000
2004 Standout
Periodontal diseases
2005 Standout
Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA
2014
Use of cancer‐specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors
2010
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
Circulating cell-free DNA: A novel biomarker for response to therapy in ovarian carcinoma
2006
249ser TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma
2005
Role of Cell‐Free Plasma DNA as a Diagnostic Marker for Prostate Cancer
2004
Molecular Detection of Tumor Cells in Bronchoalveolar Lavage Fluid From Patients With Early Stage Lung Cancer
1999
Circulating nucleic acids (CNAs) and cancer—A survey
2006
Extracellular DNA in Breast Cancer: Cell‐Surface‐Bound, Tumor‐Derived Extracellular DNA in Blood of Patients with Breast Cancer and Nonmalignant Tumors
2004
Circulating tumour‐associated plasma DNA represents an independent and informative predictor of prostate cancer
2006
Discovery of Double-Stranded Genomic DNA in Circulating Exosomes
2016
Clinical Relevance of Circulating Nucleosomes in Cancer
2008
The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinoma
2006
A Noninvasive System for Monitoring Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors with Plasma DNA
2011
Circulating nucleic acids in plasma/serum
2007
Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts
2010
Plasma cell‐free DNA in ovarian cancer
2010
Head and Neck Cancer
2001 Standout
Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults
2003 Standout
Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study
2016
Real-time reverse transcription PCR and the detection of occult disease in colorectal cancer
2006
CTR1, a negative regulator of the ethylene response pathway in arabidopsis, encodes a member of the Raf family of protein kinases
1993 Standout
Prognostic value of circulating KRAS2 gene mutations in colorectal cancer with distant metastases
2006
Nuclear DNA amounts in angiosperms
1976 Standout
Elevated Cell-Free Plasma DNA Level as an Independent Predictor of Mortality in Patients with Severe Traumatic Brain Injury
2014
Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery
2015
Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease
2015
Cancer biomarkers: Written in blood
2014 Nature
Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphoma.
2002
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
2011 Standout
Allelic Imbalance on 12q22-23 in Serum Circulating DNA of Melanoma Patients Predicts Disease Outcome
2004
Genetic Analysis of DNA Excreted in Urine: A New Approach for Detecting Specific Genomic DNA Sequences from Cells Dying in an Organism
2000
Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients: a prospect for early diagnosis.
1999
The Enigmatic Epidemiology of Nasopharyngeal Carcinoma
2006 Standout
Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA.
2000
Feasibility and relevance of global expression profiling of gene transcripts in serum from breast cancer patients using whole genome microarrays and quantitative RT-PCR.
2008
Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer
2009
Soluble normal and mutated DNA sequences from single-copy genes in human blood.
1994
Characterization of Amplifiable, Circulating RNA in Plasma and Its Potential as a Tool for Cancer Diagnostics
2004
Molecular detection of genetic alterations in the serum of colorectal cancer patients.
1998
Prediction of Breast Tumor Progression by Integrity of Free Circulating DNA in Serum
2006
Direct measurement of cell-free DNA from serially collected capillary plasma during incremental exercise
2014
Uptake of Nonviral Nucleic Acids by Mammalian Cells
1971
Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer.
2002
Digital PCR
1999
Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients.
1999
Targeting Proinflammatory Molecules Using Multifunctional MnO Nanoparticles to Inhibit Breast Cancer Recurrence and Metastasis
2022
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Neuronal production, migration, and differentiation in a vocal control nucleus of the adult female canary brain.
1983 Standout
Molecular Detection of APC, K‐ras, and p53 Mutations in the Serum of Colorectal Cancer Patients as Circulating Biomarkers
2004
Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients.
1999
Association of Circulating Tumor Cells with Serum Tumor-Related Methylated DNA in Peripheral Blood of Melanoma Patients
2006
Preoperative Serum DNA GSTP1 CpG Island Hypermethylation and the Risk of Early Prostate-Specific Antigen Recurrence Following Radical Prostatectomy
2005
Changes in mutational status during third‐line treatment for metastatic colorectal cancer—Results of consecutive measurement of cell free DNA, KRAS and BRAF in the plasma
2014
Guide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancer
2016
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
2003 Standout
Detection of aberrant p16 methylation in the serum of colorectal cancer patients.
2002
Oral administration of lipopolysaccharides activates B-1 cells in the peritoneal cavity and lamina propria of the gut and induces autoimmune symptoms in an autoantibody transgenic mouse.
1994 StandoutNobel
Predominant Hematopoietic Origin of Cell-free DNA in Plasma and Serum after Sex-mismatched Bone Marrow Transplantation
2002
Salivary Transcriptome Diagnostics for Oral Cancer Detection
2004
Agrobacterium-mediated transformation of germinating seeds of Arabidopsis thaliana: A non-tissue culture approach
1987
Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma.
1999
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
Cell-free Tumor DNA in Blood Plasma As a Marker for Circulating Tumor Cells in Prostate Cancer
2009
Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients.
2001
Microsatellite analysis of free tumor DNA in urine, serum, and plasma of patients: a minimally invasive method for the detection of bladder cancer.
2002
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
The Mutation Rate and Cancer
1998
Prognostic Value of Circulating KRAS2 Gene Mutations in Colorectal Cancer with Distant Metastases
2006
Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival.
2002
Extracellular RNA mediates endothelial-cell permeability via vascular endothelial growth factor
2007
Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma.
2002
Interferon Messenger RNA: Translation in Heterologous Cells
1972 StandoutNobel
Prospective Study of Quantitation of Plasma DNA Levels in the Diagnosis of Malignant versus Benign Prostate Disease
2005
Increased Integrity of Free Circulating DNA in Sera of Patients with Colorectal or Periampullary Cancer: Direct Quantitative PCR for ALU Repeats
2006
Nucleic Acid-Based Methods for the Detection of Cancer
1997 Science
Circulating Mitochondrial Nucleic Acids Have Prognostic Value for Survival in Patients with Advanced Prostate Cancer
2007
Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma.
1999
Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients.
2001
Preterm labor: One syndrome, many causes
2014 StandoutScience
Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA
2014
Rapid Flow Cytometric Analysis of the Cell Cycle in Intact Plant Tissues
1983 StandoutScience
Gene promoter hypermethylation in tumors and serum of head and neck cancer patients.
2000
K-ras Mutations in DNA Extracted From the Plasma of Patients With Pancreatic Carcinoma: Diagnostic Utility and Prognostic Significance
1999
Circulating Tumor DNA as Biomarkers for Cancer Detection
2017
Epstein-Barr virus DNA in serum/plasma as a tumor marker for nasopharyngeal cancer.
2000
Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients.
1999
Plasma Epstein-Barr Viral Deoxyribonucleic Acid Quantitation Complements Tumor-Node-Metastasis Staging Prognostication in Nasopharyngeal Carcinoma
2006
Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer
1997
Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma.
2001
Quantitative Analysis of Cell-Free Epstein-Barr Virus DNA in Plasma of Patients with Nonnasopharyngeal Head and Neck Carcinomas
2004
Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing
2013
Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis.
2000
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
1998 Standout
Global cancer statistics, 2012
2015 Standout
Prognostic significance of circulating microsatellite markers in the plasma of melanoma patients.
2001
Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma.
2003
DNA binding to human leukocytes. Evidence for a receptor-mediated association, internalization, and degradation of DNA.
1985
Circulating nucleic acids in plasma and serum (CNAPS) and its relation to stem cells and cancer metastasis: state of the issue.
2004
DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells.
2001 Standout
AUTORADIOGRAPHIC CONFIRMATION OF THE MITOTIC DIVISION OF EVERY MOUSE JEJUNAL CRYPT CELL LABELLED WITH 3H‐THYMIDINE
1973
Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients.
2000
Cancer Genome Scanning in Plasma: Detection of Tumor-Associated Copy Number Aberrations, Single-Nucleotide Variants, and Tumoral Heterogeneity by Massively Parallel Sequencing
2012
Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients.
2003
Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
2023 Standout
Emerging Droplet Microfluidics
2017 Standout
14-3-3σ Methylation in Pretreatment Serum Circulating DNA of Cisplatin-Plus-Gemcitabine-Treated Advanced Non–Small-Cell Lung Cancer Patients Predicts Survival: The Spanish Lung Cancer Group
2005
Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma.
2000
Measurement of Cyclin E Genomic Copy Number and Strand Length in Cell-Free DNA Distinguish Malignant versus Benign Effusions
2007
Real-Time PCR Technology for Cancer Diagnostics
2002
Effects of Breeding Environments on Generation and Activation of Autoreactive B-1 Cells in Anti-red Blood Cell Autoantibody Transgenic Mice
1997 StandoutNobel
Stability of Endogenous and Added RNA in Blood Specimens, Serum, and Plasma
2002
Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis.
2001
Works of Philippe Anker being referenced
Circulating Nucleic Acids in Higher Organisms
1977
Neoplastic Characteristics of the DNA Found in the Plasma of Cancer Patients
1989
Point mutations of the N‐ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia
1994
Detection of Circulating Tumour DNA in the Blood (Plasma/Serum) of Cancer Patients
1999
K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer
1997
Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: Time for large‐scale clinical studies?
2002
Plasma DNA K‐ras Mutations in Patients with Gastrointestinal Malignancies
2000
Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: Follow-up study and prognostic significance
2000
Recent advances in circulating nucleic acids in oncology
2019
Microsatellite alterations in plasma DNA of small cell lung cancer patients
1996
Quantitative Aspects of Plasma/Serum DNA in Cancer Patients
2000
Alu Repeat Sequences Are Present in Increased Proportions Compared to a Unique Gene in Plasma/Serum DNA
2001
Circulating nucleic acids in plasma or serum
2001
The use of genetic instability as a clinical tool for cancer diagnosis
1998
Cancer Progression Mediated by Horizontal Gene Transfer in an In Vivo Model
2012
Plasma DNA microsatellite panel as sensitive and tumor‐specific marker in lung cancer patients
2003
Microsatellite alterations in serum DNA of head and neck cancer patients
1996
Metabolic DNA as the Origin of Spontaneously Released DNA?
2008
Origins, structures, and functions of circulating DNA in oncology
2016
Isolation and characterization of DNA from the plasma of cancer patients
1987
Quantification of free total plasma DNA and minimal residual disease detection in the plasma of children with acute lymphoblastic leukemia
2009
The Origin and Mechanism of Circulating DNA
2000
Agrobacterium tumefaciens Ribonucleic Acid Synthesis in Tomato Cells and Crown Gall Induction
1971
Fate of Bacterial Deoxyribonucleic Acid in Lycopersicon esculentum
1966 Nature
Metabolic DNA in Heart and Skeletal Muscle and in the Intestine of Mice
1967 Nature
Spontaneous extracellular synthesis of DNA released by human blood lymphocytes.
1976
Bacterial nucleic acid synthesis in plants following bacterial contact
1971
Nude mice injected with DNA released by antigen stimulated human tlymphocytes produce specific antibodies expressing human characteristics
1984
Tumor-related alterations in circulating DNA, potential for diagnosis, prognosis and detection of minimal residual disease
2001
Telomerase RNA as a detection marker in the serum of breast cancer patients.
2000
Translocation of DNA of Bacterial Origin in Lycopersicum esculentum by Ultracentrifugation in Caesium Chloride Gradient
1967 Nature
Circulating DNA in Plasma or Serum
2001
Spontaneous release of DNA by human blood lymphocytes as shown in an in vitro system.
1975
Bacterial Ribonucleic Acid in the Frog Brain after a Bacterial Peritoneal Infection
1972 Science
A prospective study of K-ras mutations in the plasma of pancreatic cancer patients.
1998
[Transformation of NIH/3T3 cells and SW 480 cells displaying K-ras mutation].
1994
Microsatellite analysis of plasma DNA from patients with clear cell renal carcinoma.
1998
Presence of RNA in the nucleoprotein complex spontaneously released by human lymphocytes and frog auricles in culture.
1978
Information carried by the DNA released by antigen-stimulated lymphocytes.
1979
Nucleic acids spontaneously released by living frog auricles
1972
Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer.
1999